Expert Outlook: Health Catalyst Through The Eyes Of 7 Analysts
Expert Outlook: Health Catalyst Through The Eyes Of 7 Analysts
專家展望：健康催化劑從7位分析師的角度來看
Interpreting Analyst Ratings: A Closer Look...7 analysts have shared their evaluations of Health Catalyst (NASDAQ:HCAT) during the recent three months, expressing a mix of bullish and bearish perspectives.
在最近的三個月裏，有7位分析師對Health Catalyst（NASDAQ:HCAT）進行了評估，表達了看好和看淡的不同觀點。
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
下表提供了分析師最近的評級概述，爲了全面了解過去30天的情緒變化並與前幾個月進行比較，提供了深入的見解。
Analysts have set 12-month price targets for Health Catalyst, revealing an average target of $12.43, a high estimate of $16.00, and a low estimate of $7.00. Highlighting a 2.2% decrease, the current average has fallen from the previous average price target of $12.71.
分析師爲Health Catalyst設定了12個月的目標股價，平均目標價爲12.43美元，最高估價爲16.00美元，最低估價爲7.00美元。當前的平均目標價下降了2.2％，從之前的12.71美元的平均目標價下降。
Interpreting Analyst Ratings: A Closer Look...
解讀分析師評...
登入免費觀看全文
登入/註冊